Hypoparathyroidism: update of guidelines from the 2022 International Task Force

被引:5
|
作者
Clarke, Bart L. [1 ,2 ]
机构
[1] Mayo Clin, Div Endocrinol Diabet Metab & Nutr, Rochester, MN USA
[2] Mayo Clin, Div Endocrinol Diabet Metab & Nutr, East 18-A1,200 1st St SW, Rochester, MN 55905 USA
来源
ARCHIVES OF ENDOCRINOLOGY METABOLISM | 2022年 / 66卷 / 05期
关键词
Hypoparathyroidism; hypocalcemia; nephrolithiasis; nephrocalcinosis; increased bone density; CALCIUM-REGULATING HORMONES; PREGNANCY; PTH(1-84); EFFICACY; THERAPY;
D O I
10.20945/2359-3997000000549
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The 2022 International Task Force guidelines for chronic hypoparathyroidism will be published within several months in the Journal of Bone and Mineral Research. These guidelines update the original guidelines published in 2016, and include new information from literature published since then. Chronic postsurgical hypoparathyroidism is now defined as lasting for at least 12 months after surgery, rather than 6 months. Chronic postsurgical hypoparathyroidism may be predicted by serum PTH <10 pg/mL in the first 12-24 hours after surgery. The most common symptoms and complications of chronic hypoparathyroidism based on the literature are summarized in detail. How to monitor and manage patients with hypoparathyroidism is described in detail where recommendations can be given. These guidelines are intended to frame the diagnosis and care of patients with chronic hypoparathyroidism for at least the next five years. Arch Endocrinol Metab. 2022;66(5):604-10
引用
下载
收藏
页码:604 / 610
页数:7
相关论文
共 50 条